• by bcarlson@marketresearch.com
  • January 13 2014


IVD Companies Must Comply With Sunshine Act

IVD Companies Must Comply With Sunshine Act

Marketers for IVD products will have to disclose payments made to pathology labs, whether they come in the form of discounts, travel or small trinkets.   Congress passed the Physician Sunshine Payment Act in 2010 as part of the Affordable Care Act (ACA) to thwart the influence of financial perks on healthcare costs. Pathologists and other lab workers are included in the law’s scope.  The new rules are the same rules as followed pharma companies when it comes to the rmarketing according to a story in DARK Daily, 

"Vendors are now required to publicly disclose all payments-or “transfers of value”-to providers where the value is more than $10 or an aggregate amount of $100 annually. Manufacturers and providers, therefore, must report payments for speaking engagements, consulting fees, research grants, travel reimbursements, stock, and even small trinkets and meals during routine sales visits." - DARK DAILY

 
IVD companies are not the only entities affected.   The law also includes medical device and medical equipment manufacturers, group purchasing organizations, pharmaceutical firms, software companies, physicians, and teaching hospitals in its definition of vendors.